Home > National Drug Code (NDC) > Liposyn III

Liposyn III - 0409-9791-02 - (SOYBEAN OIL, EGG PHOSPHOLIPIDS, and GLYCERIN)

Alphabetical Index


Drug Information of Liposyn III

Product NDC: 0409-9791
Proprietary Name: Liposyn III
Non Proprietary Name: SOYBEAN OIL, EGG PHOSPHOLIPIDS, and GLYCERIN
Active Ingredient(s): 1.2; 2.5; 20    g/100mL; g/100mL; g/100mL & nbsp;   SOYBEAN OIL, EGG PHOSPHOLIPIDS, and GLYCERIN
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, EMULSION
Coding System: National Drug Codes(NDC)

Labeler Information of Liposyn III

Product NDC: 0409-9791
Labeler Name: Hospira, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA018970
Marketing Category: NDA
Start Marketing Date: 20110211

Package Information of Liposyn III

Package NDC: 0409-9791-02
Package Description: 12 BOTTLE, GLASS in 1 CASE (0409-9791-02) > 250 mL in 1 BOTTLE, GLASS

NDC Information of Liposyn III

NDC Code 0409-9791-02
Proprietary Name Liposyn III
Package Description 12 BOTTLE, GLASS in 1 CASE (0409-9791-02) > 250 mL in 1 BOTTLE, GLASS
Product NDC 0409-9791
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name SOYBEAN OIL, EGG PHOSPHOLIPIDS, and GLYCERIN
Dosage Form Name INJECTION, EMULSION
Route Name INTRAVENOUS
Start Marketing Date 20110211
Marketing Category Name NDA
Labeler Name Hospira, Inc.
Substance Name EGG PHOSPHOLIPIDS; GLYCERIN; SOYBEAN OIL
Strength Number 1.2; 2.5; 20
Strength Unit g/100mL; g/100mL; g/100mL
Pharmaceutical Classes Non-Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Glycerol [Chemical/Ingredient]

Complete Information of Liposyn III


General Information